Company intelligence / Profile preview

RobotDreams

Graz, Styria, Austriaarcadiamotionpictures.com ↗

Ownership: Private
Development stage: Other

Overview

RobotDreams has developed an AI-powered modular software platform that analyzes blood samples to diagnose cardiovascular diseases, with the first module focused on acute coronary syndrome. The technology aims to improve speed and accuracy of diagnosis in emergency settings and routine lab work, reducing unnecessary hospitalizations and missed diagnoses.

Therapeutic areas: Cardiovascular
Modalities: Non-pharmacological therapy (AI-based diagnostic software)
Industry: Digital Health Medical Devices

Partnerships

Human.technology Styria cluster memberEuropean Space Agency Commercialisation Days participant

Beyond the preview

Go deeper on RobotDreams.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RobotDreams.

Explore the full profile